At the same time, we narrowed the scope of our under-65 health insurance business, improving our risk profile and sharpening our strategic focus. While transaction value came in modestly below ...
Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...